Format

Send to

Choose Destination
Curr Opin Immunol. 2002 Aug;14(4):495-502.

Neutralizing antibodies against HIV -- back in the major leagues?

Author information

1
Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute and Department of Medicine, Harvard Medical School, Boston, MA 02115, USA. flavia_ferrantelli@dfci.harvard.edu

Abstract

The past few months have seen encouraging successes for neutralizing antibodies against HIV; human monoclonal antibodies targeting conserved HIV envelope epitopes potently neutralized primary virus isolates, including strains of different clades. In primates, passive immunization with combinations containing human monoclonal antibodies completely prevented infection, even after mucosal virus challenges. Epitopes recognized by the protective monoclonal antibodies are important determinants for protection and provide a rational basis for AIDS vaccine development.

PMID:
12088685
DOI:
10.1016/s0952-7915(02)00362-x
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center